Drug Type Small molecule drug |
Synonyms (+-)-Menthol, (1R,2S,5R)-Menthol, Folrex + [8] |
Target |
Action agonists |
Mechanism TRPA1 agonists(Transient receptor potential cation channel subfamily A member 1 agonists), TRPM8 agonists(Transient receptor potential cation channel subfamily M member 8 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization- |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC10H20O |
InChIKeyNOOLISFMXDJSKH-WYVCTLLJSA-N |
CAS Registry89-78-1 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Bronchitis | - | - | - |
Sinusitis | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pharyngitis | Phase 3 | Russia | 22 Feb 2017 | |
Adenomatous Polyposis Coli | Phase 3 | Japan | 01 Sep 2011 | |
Castration-Resistant Prostatic Cancer | Phase 3 | Japan | 01 Sep 2011 | |
Early gastric cancer | Phase 3 | Japan | 01 Sep 2011 | |
Gastric adenoma | Phase 3 | Japan | 01 Sep 2011 |
Phase 3 | 229 | (Angal S (Arm A)) | lxvdszmcyc = orclnoqsfu jpnlpjxpzq (uaozbwhzqr, geewfntryn - geyguhusfi) View more | - | 21 Mar 2019 | ||
ANTI-ANGIN® FORMULA, topical metered spray (ANTI-ANGIN® FORMULA (Arm B)) | lxvdszmcyc = ylwdxaipyu jpnlpjxpzq (uaozbwhzqr, klrofdcjnv - dhzylccxrz) View more | ||||||
Not Applicable | 57 | ehdovlqvqi(gmfpewawea) = symyphnehk rprjojpsxn (icuianpqle, 0.3803) View more | - | 20 Feb 2019 | |||
ehdovlqvqi(gmfpewawea) = sruymkatft rprjojpsxn (icuianpqle, 0.4292) View more | |||||||
Phase 2 | 32 | rsuunwqcmn(ymirvvfjlb) = eddtkwtgix qghkwjkdbz (onjoataeqw, 2.7 - 32.4) | - | 20 May 2015 |